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The most recently discovered gel-forming mucin, MUC19, is ex-
pressed in both salivary glands and tracheal submucosal glands. We
previously cloned the 392end partial sequence (AY236870), and
here report the complete sequencing of the entire MUC19 cDNA.
One highly variable region (HVR) was discovered in the 59 end of
MUC19. A total of20different splicingvariantsweredetected in HVR,
and 18 variants are able to translate into proteins along with the rest
of the MUC19 sequence. The longest variant of MUC19 consists of
182 exons, with a transcript of approximately 25 kb. A central exon of
approximately 12 kbcontains highly repetitive sequencesand has no
intron interruption. The deduced MUC19 protein has the bona fide
gel-forming mucin structure, VWD-VWD-VWD-‘‘threonine/serine-
rich repeats’’-VWC-CT. An unusual structural feature of MUC19,
which is lacking in other gel-forming mucins, is its long amino
terminus upstream of the first VWD domain. The long amino
terminus is mostly translated from the sequences in HVR, and
contains serine-rich repetitive sequences. To validate the integrity
of the MUC19 sequence, primers from both the 39 and 59 end were
used to demonstrate a similar tissue expression pattern of MUC19 in
trachea and salivary glands. In addition, antibodies were developed
against either the amino (N) or carboxy (C) terminus of MUC19, and
similar antibody staining patterns were observed in both salivary
and tracheal submucosal glands. In conclusion, we have cloned and
elucidated the entire MUC19 gene, which will facilitate understand-
ing of the function and regulation of this important, yet under-
studied, mucin gene in airway diseases.
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Mucus, a viscoelastic, gel-like substance, covers the epithelial
surface of various mammalian tissues, including the respiratory,
digestive, and reproductive tracts. Other than acting as a passive
barrier, mucus has many important functions in regulating
epithelial homeostasis and innate defense (1). The viscous and
elastic properties of the mucus gel have been suggested to be
largely caused by the physical properties and structural features
of mucin glycoproteins (1, 2). To date, 24 genes have taken the
name ‘‘MUC’’ or ‘‘Muc’’: MUC1, -2, -3A, -3B, -4, -5AC, -5B, -6
through -21, and -24 (http://ncbi.nlm.nih.gov). MUC2, -5AC,
-5B, -6, and -19 define a gel-forming mucin subfamily (3, 4).
They are all large in size (15–40 kb cDNA), and share a similar
structure and sequence homology in the conserved regions,
which include multiple ‘‘cysteine-rich’’ Von Willebrand (VW)
factor D– or VWC-like domains, a long central repeat region
containing threonine/serine–rich repeats, and a C-terminal
cystine knot (CT) domain (3, 5). These domains appear to play
essential roles in forming disulfide-linked dimers (6, 7) and
multimers (3, 8, 9). Alteration of their productions and/or
physiological properties can directly affect the composition of
mucus and airway homeostasis, which has been implicated in
various chronic airway diseases, cancer, and so forth (1, 2, 10).
Previously, we developed a novel ‘‘hidden Markov model’’–
based searching algorithm to screen for the additional gel-
forming mucin genes, which led to the discovery of both human
and mouse MUC19 (4). This finding was further confirmed by
conventional cloning and gene sequencing. Because this search
is entirely determined by the coverage of existing databases,
another main conclusion of this bioinformatic screening is that
MUC19 is the last gel-forming mucin family member in both
human and mouse. During the same time, a salivary apomucin-
like protein was independently reported through the character-
ization of a recessive mutation (sublingual gland differentiation
arrest) that affects mucous cell development in mouse sub-
lingual glands (11). The sequence of this protein perfectly
matches mouse Muc19. Soon after, mouse Muc19 was completely
sequenced and shown to have a cDNA length of 22,795 bp
encoded by a total of 43 exons and spanning 106 kb of genomic
DNA (12). It has a gel-forming mucin structure signal peptide,
a large central exon with tandem repeats, VWC, VWD, and C-
terminal CT domains. Interestingly, the mouse Muc19 locus
contains an additional transcript, submandibular gland protein
C (Smgc) (12). Smgc is a major secretory product, and a marker
of the type I (terminal tubule) cells of the neonatal rat and
mouse submandibular gland, but its expression in the adult is
present only in some intercalated duct cells (13). It contains 18
exons. The first exon overlaps with Muc19, and the rest of the
sequences are located in intron 1 of Muc19 (12, 13).
Similar to MUC5B/Muc5b, MUC19/Muc19 is expressed by
mucous cells of tracheal submucosal glands and salivary glands
(4). However, differences between these two gel-forming mucin
genes were recently reported in mouse salivary glands. Al-
though both Muc5b and Muc19 were expressed by the minor
salivary glands, the major glands (i.e., sublingual and subman-
dibular glands) appear to only express Muc19, but not Muc5b
(14). Beyond these two organs, Muc19 was detected in bul-
bourethral glands (Cowper’s glands) in the male reproductive
system (14), and MUC19 was detected in lacrimal glands of the
ocular system (15). Thus, normal MUC19/Muc19 expression
appears to be restricted to the glands of various organ systems.
However, under certain disease conditions, it is expressed in the
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epithelium. Two recently reported examples are increased
MUC19 expression in middle ear epithelium from patients
having either recurrent otitis media or chronic otitis media with
effusion (16), and elevated expression of MUC19 in nasal
epithelial cells of patients with allergic rhinitis (17).
Relative to other gel-forming mucins, MUC19 is under-
studied, particularly in the airway. To date, regulation and
potential functional implications of MUC19/Muc19 have only
been reported in patients with Sjogren syndrome (15), in
cytokine-challenged middle ear epithelium (18), in an allergic
mouse model (19), and in a mouse model of mucous cell de-
ficiency in salivary glands (11). One main obstacle is the lack of
complete human sequence. The short 39 end (2.1 kb) that we
have reported contains mostly repetitive sequences. The unique
sequence, which is suitable for primer design, is very short.
Although complete mouse Muc19 has been reported, it has very
little use in respiratory research, because MUC19/Muc19 is
mainly expressed in the glandular mucous cells of the airway,
and the mouse has a very limited submucosal gland structure.
To advance the study on this relatively new mucin, we de-
termined to complete the sequence of human MUC19.
MATERIALS AND METHODS
Tissues, RNA, Chemicals, Antibodies, and Kits
Human trachea and salivary gland tissue samples were obtained from
the National Disease Research Interchange under an approved pro-
tocol. Tissue RNA panel and premium-quality tissue RNA (pooled)
from salivary gland and trachea were purchased from Clontech
(Mountain view, CA) and used for rapid amplification of cDNA end
(RACE) and RT-PCR. The RACE kit was purchased from Roche
(Roche Diagnostics Corp., Indianapolis, IN). PCR primers were syn-
thesized by Sigma (St. Louis, MO). Chicken anti-human MUC19
antibodies (hMUC19Ab_C1) was generated by using a C-terminus
antigen (CREENYELRDIVLD), and hMUC19Ab_N1 was generated by
the N-terminus antigen, CGSYNNKAEDDFMSSQNILEKTSQ. These
were made, affinity purified, and ELISA tested by Aves Labs Inc. (Tigard,
OR). Horseradish peroxidase–conjugated goat anti-chicken IgG was
purchased from Aves Labs Inc. Tyramide signaling amplification (TSA)
plus fluorescein kit was purchased from PerkinElmer (Waltham, MA).
59-RACE
The RACE kit was used to obtain the cDNA ends (4, 20). Briefly,
Oligo-dT anchor primer or antisense gene-specific primers correspond-
ing to different regions of the MUC19 message were used to initiate
first-strand cDNA synthesis. Then, 59 tailing with oligo d(G) (or dA,
dT, dC) with terminal deoxynucleotidyl transferase was performed on
the first-strand cDNA. A PCR was performed using the nested gene-
specific primer and the 59 oligo d(T) anchor primer. The PCR products
were subcloned into aTA vector (Invitrogen, Carlsbad, CA) for cloning
and DNA sequencing. All primer sequences used in this study are
listed in Table 1.
RT-PCR Amplification
cDNA was synthesized from total RNA (3 mg) by RT with oligo d(T)
primer. The resulting single-strand cDNA was used as a template for
PCR amplification by MUC19 gene-specific primers (Table 2). PCR
products were TA cloned and sequenced.
Genomic Walking and Sequencing
Human tracheal DNA was extracted using a genomic DNA kit from
Qiagen (Valencia, CA). PCR was performed using the primers (Table 2)
designed for cDNA cloning. PCR products were cloned into a TA vector
(Invitrogen; for cloning and DNA sequencing) and subject to sequenc-
ing. To count for the variation between subjects, the same genomic
fragment from the second individual was also cloned and sequenced.
Genomic Structure and Localization
The genomic structure of MUC19 was determined by Blat search of the
most up-to-date human genome assembly, GRCh37/hg19 (University
of California, Santa Cruz, Santa Cruz, CA).
Phylogenetic Analysis
All nonrepetitive 59 end peptide sequences from gel-forming mucins of
different species were aligned using the ClustalW program (www.ebi.
ac.uk/clustalw/). The alignment was edited and the tree was built with
the Jalview program (http://www.jalview.org).
Immunofluorescence
For immunofluorescence, human trachea or salivary gland tissues were
fixed in 4% paraformaldehyde and then embedded in paraffin. Sections
were prepared in the histology facility at Southwest Environmental
Health Center (University of Arizona, Tucson, AZ). The tissue sections
were incubated with 1:100 diluted anti-MUC19 antibody overnight at
48C. Anti-chicken IgG secondary antibody (Aves Labs Inc.) and TSA
plus fluorescein kit (PerkinElmer) were used to obtain the fluorescence
images. The images were acquired by confocal microscopy (LSM 510
meta; Carl Zeiss, Thornwood, NY).
RESULTS
Cloning and Sequencing the Entire MUC19 cDNA
Gel-forming mucins all have evolutionarily conserved cDNA
structures: 59 end unique sequence–large undisrupted central
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exon 39 end unique sequence. The reported cDNAs of mouse
(12) and pig (21) MUC19 have confirmed this notion. Thus, our
general strategy was to start cloning and sequencing from both
the 59 and 39 ends until reaching the central exon. Because it
contains only repetitive sequences and has no intron disruption
(12, 22), the central exon is easy to identify by referencing the
published genomic sequences in the MUC19 locus.
Using our published 39 end MUC19 sequence (AY236870),
we were able to design RACE primers (Table 1) to extend
further upstream. Three rounds of RACE (M19RC1, M19RC2,
and M19RC3) were performed, and approximately 4.8-kb se-
quences were identified. At the third round, the sequences were
filled with repetitive sequences, suggesting that the central exon
had been reached. These results were further verified by RT-
PCR (M19RT1–3). We designated those additional sequences
starting from M19RC1 (including some overlapped sequences
of AY236870) as MUC19_4.8K (Figure 1).
We then went on to determine the 59 end of MUC19. There
are usually considerable similarities among the gel-forming
mucin orthologs across different species (4). In our previous
report, we demonstrated that pig MUC19 (AF005273, also
called porcine submaxillary gland mucin) is the closest ortholog
of human MUC19 (4). Thus, we used the 59 end cDNA
sequence of pig MUC19 to search for the similar sequences in
the genomic sequence of chromosome 12 (http://genome.ucsc.
edu/), where the MUC19 locus resides. Indeed, a large piece of
the pig MUC19 59 end sequence matches the sequence from
human MUC19 locus, and these matched human sequences
were also approximately 18 kb upstream of our published 39
end of MUC19 (AY236870). Thus, those sequences were very
Figure 1. Cloning strategy.
The top rectangular box repre-
sents human MUC19 cDNA: the
empty portion is the 59 end, the
patterned potion is central
exon, and the filled portion is
the 39 end. Four thick lines di-
rectly beneath cDNA represent
three major cDNA fragments
obtained during the cloning
process, and AY236870 is pre-
viously reported human MUC19
39-end partial cDNA sequence.
The 59-end rapid amplification
of cDNA end (RACE) products
are represented by arrows. RT-
PCR products are represented
by thin lines flanked by two
inward arrows indicating a pair
of primers. Three thin lines at
the bottom represent three
matching EST (expressed se-
quence tag) clones.
Figure 2. Characterization of highly variable
region (HVR). (A) The top rectangular box
represents the partial human MUC19 cDNA;
the empty portion is the 59 end, and the
patterned potion is the central exon. Both
M19RC6 and M19RC7 are 59 RACE prod-
ucts. Dashed lines indicate the existence of
multiple products. (B) Different HVR tran-
scripts. The 13 rectangular boxes represent
different exons. The existence of any of
those exons is represented by an ‘‘X.’’ Two
altered forms of exon 4 are represented by 4’
and 40, respectively. And one altered form of
exon 6 was represented by 6’. The details of
those exons are discussed in the RESULTS
section and in Table 3.
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possibly our 59-end human MUC19. We then designed primers
to perform 59-end RACE to uncover further upstream sequences.
Two rounds of RACE (M19RC4 and M19RC5) were per-
formed, and approximately 3 kb additional sequences were
identified (designated MUC19_3K) (Figure 1). Using MUC19_3K,
we searched dbEST, the Expressed Sequence Tags database
(http://www.ncbi.nlm.nih.gov/projects/dbEST/) and uncovered
three EST clones (DR007976, DV080669, and DV080670) that
overlap with each other and are downstream of MUC19_3K.
Those clones were confirmed by resequencing. In addition, we
designed various RT-PCR reactions to verify the sequences
from the RACE and from the EST clones. A total of 6 RT-PCR
products (M19RT4–9) were obtained and sequenced, and the
results confirmed a single transcript of approximately 4.6 kb
(designated MUC19_4.6K) (Figure 1).
Because the genomic sequences were completed in the
MUC19 locus (http://genome.ucsc.edu/), we evaluated the se-
quences between the MUC19_4.6K (59 end) and the MUC19_4.8K
(39 end). Indeed, the entire region has only repetitive se-
quences, and consists of a single giant open reading frame
(ORF), suggesting that it should be the central exon. The
transitional sequences between the central exon and its 59/39
end were confirmed using the primer pairs across the junctions
(M19RT3 and M19RT10 primer pairs; see Table 2) (Figure 1).
To confirm that it is indeed a single exon, we further designed
several pairs of primers inside the central exon. The RT-PCR
products (M19RT11–13) indicated the predicted sequence
without any intron disruption. However, the sequences down-
stream of M19RT13 became extremely repetitive and degen-
erated. Thus, we were unable to test any additional regions in
the central exon. Nonetheless, the highly repetitive sequence,
the entire sequence being a single ORF, and the pilot PCR
verifications all suggested that this was the central exon.
Discovery and Characterization of a 59-End Highly
Variable Region
Although MUC19_4.6K appears to be a single transcript, the
products from the additional 59 RACE (M19RC6) had very
complicated compositions, suggesting that they may not be de-
rived from a single transcript. As shown in Figure 2A, We then
designed a different reverse primer (M19RC7), which was 301
bp upstream of M19RC6. The RACE result from M19RC7
appeared to be similar to the M19RC6 (i.e., multiple products
with overlapping but different compositions), suggesting that
the multiple RACE products were not caused by the nonspecific
priming. To identify all those transcripts, we cloned and sequenced
as many RACE products as possible. A total of 100 transcripts was
cloned and sequenced, and 20 nonredundant sequences were
identified (Figure 2B). Alignments with the reported human
genome sequences (GRCh37/hg19) indicate that they mostly
consist of different combinations of 13 exons (Figure 2B). Exon
4 has two other forms with the same 59 end, but a different 39 end:
49 is 20-bp shorter and 40 is 195-bp longer. In contrast, two forms of
exon 6 exist with a different 59 end but the same 39 end, and
exon 6 is 81-bp longer than exon 69. The longest transcript has
all 13 exons, and the shortest only has 8. Considering the
existence of so many alternative splicing transcripts, we named
this region the highly variable region (HVR). The sequences
of those 20 splicing forms (HVR_1–20) have been deposited in
GenBank with the accession numbers HM801843–801862.
Determination of the Transcription Start Site
Despite the nature of multiple transcripts, both M19RC6 and
M19RC7 RACE products stopped at the same nucleotide
(Figure 3A), and the additional RACE reactions using the
reverse primers designed accordingly to the sequences in both
the common and variable regions of HVR produced no further
59-end sequence (data not shown). In addition, because the
RACE product had 59-end artificial tailing of the nucleotides
(dG was added in our original tailing reactions), we tried another
three different tailing nucleotides (dA, dT, dC), and confirmed
that the ‘‘A’’ was the transcription start site (TSS; Figure 3A). A
putative TATA box (TATAAAA) was identified 30-bp up-
stream of TSS, and a translation start codon (ATG) with Kozak
consensus sequence (23) was identified 54-bp downstream of
Figure 3. Characterization of
transcription start site (TSS). (A)
TATA box ismarked by underline.
An arrow and capitalized letter
indicates the TSS. The Kozak
sequence is marked by a rectan-
gular box. Nonmatched cDNA:
cDNA sequences that don’t
match with GRCh37/hg19,
leading to discovery of the addi-
tional genomic sequence,
HM801863. (B) The alignment
of MUC19 sequences near TSS.
c, chimpanzee; h, human; m,
mouse; p, pig; r, rat. *Identical
nucleotides.
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TABLE 3. EXON/INTRON STRUCTURES OF THE LONGEST MUC19 VARIANT (HM801842)
Exon Size Intron Size
Exon No. Intron 39 Sequence Exon 59 Sequence Exon 39 Sequence Intron 59 Sequence (bp) (bp) Protein Domains
1 — AGACTT TCAAAG gtaaga 106 4,380 —
2 aaatag ATGTGG AATCAG gtcagt 33 2,130 —
3 cttcag ATGGTA GATCAG gtaaat 27 5,957 —
4* ctgtag GTGGCT CAGCAG gtactg 150 2,053 —
5 ctgtag GTGGCT CACCAG gtaccg 150 3,658 —
6* ctgtag GTGGCT CAGCAG gtactg 150 2,286 —
7 cagcag ATAGCA GCTCAG gtattc 186 142 —
8 cattag TTGGAA ATCTAG gtatta 165 87 —
9 ctgcag GTGATA GCTCAG gtattc 183 820 —
10 caacag GTGATT ACTCAG gtatcc 183 88 —
11 caacag GTGATT ACTCAG gtatcc 42 1,771 —
12 cattag GAGGAA GAGGAG gtaaga 51 994 —
13 gaatag AAAAAG TTATTG gtaagt 60 974 VWD
14 ttatag GTGAAA AGAAAG gtaaat 229 771 VWD
15 tttcac TGTACA CTCTCG gtaagt 118 517 VWD
16 ttaaag CTCACT CTCCAG gtaaca 61 204 VWD
17 tttaag GGCAAG ATACAG gtaaga 98 4,206 —
18 ttgtag CACTGT TTTGTG gtaggt 211 757 —
19 tccagg AACACA CAGAAG gtagta 123 474 —
20 ttctag GTTATC TCAGTG gtatgt 124 1,449 VWD
21 taatag CACATG GTTCAC gtatgt 136 1,949 VWD
22 ttacag AATGAA AATTCT gtaagt 93 660 VWD
23 tattag TCTGTT ATTCAG gtaagt 85 165 VWD
24 taacag ATAAAA CTGTGG gtaagt 138 1,000 VWD
25 acacag GACTCT AAAAAG gtaata 150 2,184 —
26 ttccag AAAATT CATGAG gtatgt 95 426 —
27 ttcaag GAATGC TATGTG gtaagc 127 1,385 —
28 caacag AACATT TAAATG gtatgg 247 2,199 —
29 ttccag CGTCTG CCCTAC gtaagt 54 98 —
30 ctgcag AAAATT TTTGAT gtaagt 101 237 —
31 ttgtag GAGAAC TGAATG gtgctt 152 660 VWD
32 ttttag TACCTG CTTGAG gtaatt 139 1,066 VWD
33 ttaaag GATTAT TTTCAG gtacag 105 86 VWD
34 ttacag GATCAG TGGAAT gtatgt 195 617 VWD
35 atacag GGCAAA AACAAG gtagca 240 73 VWD
36 gcctag GTTGAC TGTGTC gtaagt 157 974 —
37 ttacag CTGTCT TAGAAG gtaaga 126 844 —
38 acacag GTTGTT AACATG gtatat 142 696 —
39 tttcag CTACTG GCAGTG gtaagt 32 810 —
40 tttcag AAACTG TTGCAG gtaaaa 30 1,494 —
41 aaacag TTTCCA GAGCAG gtaaat 42 531 —
42 gcatag CAATTA GCACAG gtaagc 33 379 —
43 attcag CAGCAT CAACAG gtaggt 45 8,015 —
44 ttttag GAACAA CTACAG gtcagt 39 1,466 —
45 tctcag GCATTA TGGCAG gtaaat 99 3,107 —
46 aagtag GAACAA GAGCAG gtactg 66 615 —
47 aattag GCACAC TTTCTG gtaaga 84 218 —
48 tttcag GAAGTA AATCAG gtaagt 78 641 —
49 tgaaag GAACTA TGTCAG gtgagt 75 242 —
50 tgtcag GTGTAA GTGGTG gtgagt 135 384 —
51 aattag GAACAA CATTGG gtatgg 66 7,103 —
52 gaccag GTTCAA CAGCAG gtaaga 99 1,521 —
53 tgaaag TCTCAG AATCAG gcaagt 102 235 —
54 aaccag GGACCC AACCAG gtaggt 102 373 —
55 ccacag GTACAC CACCAG gtgaga 96 3,388 —
56 tgacag GGGCAA TAACAG gtacaa 12253 2,642 Central exon
57 attcag CTACAA CGTCAG gtactg 66 107 —
58 tctcag TTGCCA CTACTG gtaagt 54 4,072 —
59 tttcag GTACCA ACATAG gtgaga 54 656 —
60 tttcag GAACTT TCTCAG gtaagt 54 398 —
61 tctcag AGGCTA CAGGAG gtgagt 45 249 —
62 tcacag GCACCA ACACAG gtaaaa 54 425 —
63 ttttag GTATCA ACACAG gtaaag 54 925 —
64 tttcag CTACGA GTACAG gtgagt 54 152 —
65 tctcag AGGCCA CCACAG gtgagc 54 632 —
66 tctcag AAGCCA CAGAAG gtaagc 54 1,382 —
67 ttttag GTACTT ACACAG gtagtt 54 135 —
68 tctcag AAGCCA GAGCAG gtgagg 54 673 —
69 tctcag AGTCCA TGACAG gtgagc 54 669 —
70 tctcag AGGCCA CAGGAG gtaagg 54 954 —
(Continued )
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TABLE 3. (CONTINUED)
Exon Size Intron Size
Exon No. Intron 39 Sequence Exon 59 Sequence Exon 39 Sequence Intron 59 Sequence (bp) (bp) Protein Domains
71 ttttag GTACCT ACACAG gtagtt 54 139 —
72 cctcag AGGCCA GAACAG gtgagg 54 2,472 —
73 tttcag CCACCA AGACAG gtaagt 54 149 —
74 ccttag AGGCCA CCACGG gtgagt 54 599 —
75 tctcag GGGCCA CAGGAG gtgagc 54 990 —
76 ttttag GTACTT ACACAG gtagtt 54 125 —
77 ccacag AGGCCA CAGTAG gtgagg 54 895 —
78 tctcag AGACCA CCACGG gtgagc 54 814 —
79 taatag CTACCA ACACAG gcaagt 54 121 —
80 tctcag AGGCCA CAGGAG gtaagg 54 938 —
81 ttgtag GTACCT ACACAG gtagtt 54 132 —
82 tctcag AGGCCA AGACAG gtgagg 54 686 —
83 tttcag CCACCA ATACAG gtgagt 54 157 —
84 tctcag GGGCCA CCACCG gtgagc 54 575 —
85 taatag CTACCA ACACAG gcaagt 54 121 —
86 tctcag AGGCCA CAGGAG gtaagc 54 966 —
87 ttgtag GTACTT ACACAG gtagtt 54 872 —
88 tttcag CCACCA ACACGG gtgagt 54 157 —
89 tctcag GGGCCA CCACCG gtgagc 54 575 —
90 taatag CTACCA ACACAG gcaagt 54 121 —
91 tctcag AGGCCA CAGGAG gtaagc 54 1,144 —
92 cctcag AGGCCA GAACAG gtgagg 54 1,308 —
93 tttcag CCACCA AGACAG gtaagt 54 149 —
94 ccttag AGGCCA CCACGG gtgagt 54 606 —
95 tctcag GTGCCA CAGGAG gtgagc 54 532 —
96 taatag GTACAA GGCCAG gtagga 54 146 —
97 ctgaag GCACCT AAACAG gtgagg 45 224 —
98 tttag TTACTA ACACCG gtaggt 54 606 —
99 tgacag GCACCC TGACAG gtgaag 45 269 —
100 tttcag CCACCA ACACAG gtgagt 54 147 —
101 tctcag AGGCCA TCACAG gtgagc 54 1,186 —
102 ttttag GTGACA CCACAG gtagtt 54 605 —
103 tcacag CAGGCA AAGCAG gtgagc 33 263 —
104 ttccag GCACCT GCACAG gtgagt 54 144 —
105 ttccag CAGCCA CTACAA gtaaga 54 863 —
106 ttcaag AGACCA AATCAG gtaaag 54 455 —
107 gtggag CCACCA GGACAG gtaaac 30 268 —
108 acctag GCACAG ACTCAG gtaaag 54 138 —
109 ttgcag AGGCCA TCACAG gttagc 54 1,675 —
110 catcag AGGCCA AAACTG gtgaga 54 696 —
111 tttcag GCACCT GCACAG gtgagt 54 144 —
112 ttccag CAGCCA CTACAA gtaaga 54 874 —
113 ttttag AGACCA AATTAG gtaaag 54 503 —
114 tttcag TAGGAA GGACAG gtaaac 36 276 —
115 gcacag CTGGAG ACTCAG gtaaag 48 138 —
116 ttgcag AGGCCA TCACAG gtgagt 54 652 —
117 tctcag AGGCCA CCAGAG gtgagc 54 770 —
118 ttttag GTACCA ACACAG gtagct 54 142 —
119 catcag AGGCCA AAATTG gtgaga 54 411 —
120 tcacag CAGGCA AAGCAG gtgagc 33 270 —
121 tttcag GCACCT GCACAG gtgagt 54 147 —
122 tcgcag CCACAA ACTCAG gtaagc 51 870 —
123 tttaag AGACCA AATCAG gtgaag 54 1,043 —
124 gcacag CTGCAG ACTCAG gtaaag 48 138 —
125 ttgcag AAGCCA TCACAG gtgagc 54 546 —
126 tttcag ATACTA ACACAG gtcagg 54 99 —
127 tctcag AGGCCA CAGGAG gtgagc 54 767 —
128 ttttag GTACCA ACACAG gtagct 54 147 —
129 cctcag AGGCCA AAACTG gtgaga 54 743 —
130 tttcag GCACCT GCACAG gtgagt 54 155 —
131 caatag CCACAA CCGCAG gtaagc 51 873 —
132 tttaag AAACCA AATCAG gtaaag 54 502 —
133 cattag GAGCCA AGACAG gtaaac 33 270 —
134 atctag GCACAG ACTCAG gtaaaa 54 138 —
135 ttacag AGGCCA TCACAG gtgagc 54 508 —
136 tttcag GTACTA ACACAG gtcagg 45 97 —
137 tgtcag AGGCCA TGGGTG gtgagc 54 481 —
138 ctgtag GCGCTT AAACAG gtcagc 45 439 —
139 cctcag AGCCCA AAACTG gtgaga 54 420 —
140 tcacag TAGGCA AAGCAG gtgagc 33 234 —
(Continued )
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TSS (Figure 3A). Sequence alignment indicates high similarities
around the TATA box and the translational start site (ATG)
among MUC19 gene of human, chimpanzee, mouse, rat, and pig
(Figure 3B).
Overall MUC19 Genomic Organization and Identification
of a Missing Genomic Fragment Downstream
of the Central Exon
To obtain the genomic structure, we compared our cDNA
sequence with the published human genomic sequences of
MUC19 locus (GRCh37/hg19) (Table 3). We found that a frag-
ment of 540bp cDNA (764-bp downstream of the central exon)
had no match (showed as ‘‘nonmatched cDNA’’ in Figure 3A).
Therefore, we used corresponding RT-PCR primers (Table 2)
to perform genomic walking in this region, and identified 7,538-
bp additional genomic sequences (deposited in GenBank
with accession no. HM801863) that perfectly matched our cDNA
sequence, but was missing from the current genome assembly
(GRCh37/hg19). To account for human-to-human variation, we
further tested the tracheal DNA samples from another individ-
ual, and the similar missing genomic sequences were also present
in this genome. Thus, the current genome assembly (GRCh37/
hg19) appears not to be complete at this location.
Interestingly, there is a large number of exons (total 122)
containing very short sequences (from 32–66 bp, and mostly
54 bp) in the regions of MUC19_4.8K and AY236870 (Table 3).
TABLE 3. (CONTINUED)
Exon Size Intron Size
Exon No. Intron 39 Sequence Exon 59 Sequence Exon 39 Sequence Intron 59 Sequence (bp) (bp) Protein Domains
141 tttcag GCACCT GCACAG gtgaat 54 139 —
142 tgccag CAGCCA CTTCAA gtaagc 54 887 —
143 tttaag AGACTA AATCAG gtaaat 54 682 —
144 tattag GAGCCA AGACAG gtagat 33 2,058 —
145 tttcag ATATCA ACACAG gtagcc 54 143 —
146 cctcag AGGCCA AAACTG gtgaga 54 406 —
147 tcacag CAGGCA AAGCAG gtgagc 33 256 —
148 tttcag GCACCT GCACAG gtgagt 54 150 —
149 tctcag CAGCTA CTGCAG gtaagc 54 971 —
150 tttaag AGACCA AATCAG gtgaag 54 510 —
151 cattag GAGCCA AGACAG gtaaat 33 255 —
152 gcctag GCACAG ACTCAG gtaaag 54 138 —
153 tctcag AGGCTA AAAATG ggaagt 54 167 —
154 ctacag GATCTA AAACAG gtgagc 48 239 —
155 tcttag TGATTC TTACAG gtaagt 63 558 —
156 cattag GAACCA AAACAG gtaaat 48 393 —
157 tttcag GCACTA GTACAG gtaggc 54 154 —
158 ttccag AAGCCA AGACAG gtgaga 54 479 —
159 ttttag GAGCTA CAATAG gtaaat 48 590 —
160 tctaag AAGCTA ATACAG gtgagc 54 753 —
161 ttttag GTACTA ACACAG gtgagt 54 966 —
162 cattag AAGCTA AAATAG gtaagc 48 252 —
163 ctttag GCACCA ACACAG gtaacc 54 156 —
164 acttag AAGCCA AAATAG gtgggc 54 324 —
165 ttgcag TTACCA ACACAA gtgagt 54 146 —
166 cctcag AGGCTA CAACTG gtgagt 54 6,411 —
167 ctttag GGATCA AAACAG gtgagc 51 269 —
168 tcccag GCTACA GAACAG gtaagt 54 576 —
169 tgtcag GCAATA AAGAAG gtgaga 42 1,101 —
170 ttgcag GAACCA TCTCAG gtaata 54 1,248 —
171 ttttag GTCCTT CCACAG gtaagt 54 415 —
172 aagcag TCACTG AAACAG gtgagt 51 285 —
173 tgcaag GCTCCA AGCCAG gtaaaa 54 170 —
174 tctcag AAACCA AAACAG gtcagt 48 1,922 VWC
175 acacag AATGTC CTCCAG gtaata 30 1,953 VWC
176 caacgg TTTGTC AAATCT gtaagt 32 89 VWC
177 atgatg CCTGGA ACTGTG gtgtgt 163 331 VWC
178 tttcag AACCAA TATGAG gtaagg 38 1,435 —
179 tcccag ATTGGT AAGCAA gtcatc 115 1,295 —
180 aggaag ACAGAA ATACAT gtgagt 36 654 CT
181 ttttag GTAAGA TGCCAA gtgagt 109 659 CT
182 ttttag GTACAA — — 295 — CT
Alternative exons
49 ctgtag GTGGCT TCCAAA gtcaga 130 — —
40 ctgtag GTGGCT GCCCTG gtaata 345 — —
69 ctacag GAGAGG CAGCAG gtactg 69 — —
Definition of abbreviation: bp, base pair.
Exon No. indicates the order of exons (e.g. 1 indicates the first exon); Intron 39 Sequence indicates part of the nucleotide sequences of the 39 end of the previous
intron at the intron and exon junction; Exon 59 Sequence indicates the part of the nucleotide sequences of the 59 end of the current exon at the intron and exon junction;
Exon 39 Sequence indicates part of the nucleotide sequences of the 39 end of the current exon at the intron and exon junction; Intron 59 Sequence indicates part of the
nucleotide sequence of the 59 end of the next intron at the intron and exon junction; Exon Size indicates the length of the exon; Intron Size indicates the length of the
intron at the 39 end of the current exon; Protein Domains indicates the documented protein domains.
* Alternative exons.
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Overall, combined with the exons in HVR, the longest MUC19
transcript has 182 exons (deposited in GenBank with accession
no. HM801842) (Table 3), in contrast to mouse Muc19, which
has 60 exons (12).
Analysis of MUC19 Protein Structure
The deduced MUC19 protein from the longest transcript has
8,385 amino acids with the classic gel-forming mucin structure:
three N-terminal VWD domains, highly repetitive sequences
encoded by the central exon (see Table E2.2 in the online
supplement), and one VWC domain and one CT domain at the
C terminus (Figure 4A). The amino acid sequences encoded by
the central exon are serine (S; 13.5%), threonine (T; 23.5%),
glycine (G; 21.6%) rich (Table E1.2), and contain numerous
potential O-glycosylation sites (www.cbs.dtu.dk). In addition,
the repetitive sequences appear to continue downstream of the
central exon (Figure 4A), and the amino acid sequences encoded
by exons 57–173 are also highly repetitive (Table E2.3) and S
(14.5%)/T (24.2%)/G (17%) rich (Table E1.3). In contrast, the
amino terminal nonrepetitive sequences of MUC19 contain
normal compositions of S, T, or G (Table E1.4).
One unusual structure of MUC19 is its long amino terminus
(mostly translated from HVR) above the first VWD domain
(located in exon 14) (Figures 4A–4B, Table 3), which is missing
not only from the other gel-forming mucins, but also from its
own orthologs (12, 21). Further analysis of this HVR translated
peptide indicates that it also contains several highly repetitive
sequences (Table E2.1). However, interestingly, the HRV
encodes mostly the serine-rich repeats (Table 1.1), but not the
threonine-rich repeats by the central exon (Table 1.2) or the
exons downstream of the central exon (Table 1.3). This serine-
rich repetitive structure is reminiscent of mouse/rat Smgc (13),
a protein encoded by an alternate transcript from the intron 1 of
Muc19 (12). The Smgc transcript shares first exon with Muc19,
and has an additional 18 exons located in intron 1 of Muc19
(12). Smgc protein contains serine-rich repetitive sequences and
resides close to the first VWD domain (in exon 3) of mouse
Muc19 (12). The N-terminal signal peptides of Smgc and
MUC19 (predicted by SignalIP; www.cbs.dtu.dk [24]) share
significant similarities (Figure 4C). Although the relationship
could not be established because of the lack of direct sequence
similarity in the regions other than signal peptides, the structure
and the location related to the VWD domain of MUC19 suggest
that the peptide encoded by HVR could be the human coun-
terpart of mouse Smgc.
As previously suggested, the gel-forming mucins have sig-
nificant homology with each other (4, 25). Thus, we compared
the protein sequences of family members (MUC2, -5AC, -5B,
-6, and -19) from various species. Some related gel-forming
mucin-like or mucin-related molecules (chicken ovomucin, frog
integumentary mucin [fIBM.1], and VWF and spiggin from fish)
were also included to probe potential evolutionary relation-
ships. As shown in Figure 5, Ovomucin, encoding an egg white
protein, appears to be the ortholog of both MUC5AC and
MUC5B in the chicken, and fIMB.1 and spiggin are orthologs of
MUC19. The MUC19 gene family appears to be the first gel-
forming mucin to branch out from the common ancestor gene
with hVWF. The appearance of four 11p15 gel-forming mucins
occurred after the separation of MUC19, and the separation
between MUC5AC and MUC5B was the most recent event.
Expression of MUC19 Using Both 39-End and 59-End
Sequence Information
To further confirm that both 39-end and 59-end sequences are
indeed obtained from a single gene, we first used PCR primers
(Table 2) corresponding to either 39-end (M19RT14) or 59-end
(M19RT15) MUC19 sequences to screen MUC19 expression
pattern in a multiple-tissue panel (20 human tissues). The
amplification products were confirmed by cloning and sequenc-
ing. Both primer sets demonstrated a similar expression pattern
Figure 4. Analyses of
MUC19 protein. (A)
The whole rectangular
box indicates the entire
MUC19 protein of 8,385
amino acids (aa). The
dotted box at the very
beginning represents
long amino terminus
(LAT). The three boxes
filled with horizontal
lines represent three
Von Willebrand (VW) D
domains. The box filled
with diamonds repre-
sents the repetitive se-
quences encoded by
the central exon. The
box with the grid repre-
sents the repetitive se-
quences encoded by
the exons downstream
of the central exon. The
box with the diagonal
lines represents the
VWC domain. The filled
box represents the cystine knot (CT) domain. The five upward arrows highlight the five classical mucin domains: three VWD domains, one VWC, and
one CT domain. (B) The LAT sequence of MUC19 upstream of the first VWD domain. The underlined sequence is putative signal peptide, and the
arrow indicates the potential cleavage site. (C ) The alignment of the signal peptide among MUC19 and Smgc proteins. The numbers on top (i.e., 10,
20) indicate the position of the amino acid (e.g., 10 represents the 10th amino acid from the left). Periods represent the gap to facilitate the
alignment. Similar sequences are marked by gray boxes. h, human; m, mouse; p, pig; r, rat.
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in both trachea and salivary glands (Figure 6). This pattern is
consistent with the reported Muc19 expression in mouse tissues
(14), except that, unlike the mouse panel (14), bulbourethral
glands were not present in the human tissue panel. Subse-
quently, we developed antibodies hMUC19Ab_N1 (against
N-terminal region) and hMUC19Ab_C1 (against C-terminal
region) to determine protein expression. Both antibodies were
affinity purified and verified using ELISA. Immunofluorescent
staining indicated similar staining patterns (Figures 7B and 7E
were the staining images from hMUC19Ab_N1 and Figures 7C
and 7F were the staining images from hMUC19Ab_C1) for both
tracheal submucosal gland (Figures 7B–7C) and salivary gland
(Figures 7E-7F), whereas the preimmune serum demonstrated
no staining (Figures 7A and 7D).
DISCUSSION
In the gel-forming mucin gene family, MUC19 has an unusual
discovery path that appears different from all others. Pig
MUC19 (also called porcine submaxillary gland mucin [PSM])
was among the first gel-forming mucins discovered and cloned
more than a decade ago (21). It was primarily used as a model to
study the biochemical properties of mucus. However, no
attempt was made to identify its human or rodent orthologs.
Recently, both Culp and colleagues (11, 12) and our group (4)
independently discovered the rodent ortholog of Muc19
through different approaches. In addition, using a bioinformatic
approach, we further identified and cloned the human MUC19
gene (4). Phylogenetic analysis revealed, for the first time, that
PSM is actually the pig MUC19 (4). These findings put this long-
time model mucin, PSM, on a par with the other gel-forming
mucin family members that have orthologs across mammals.
It has been shown that, among all mucins, gel-forming mucin
appeared early in metazoan evolution (25). In addition, epithe-
lial gel-forming mucins have been shown to have a common
ancestor with endothelial factor VWF (3). The present study
indicates that the MUC19 gene separated from the other gel-
forming mucins later than its separation from VWF. Besides, the
other four gel-forming mucins (MUC2, -5AC, -5B, and -6) are
more related to each other than to MUC19, suggesting their
appearances occurred after their separation from MUC19.
MUC19 orthologs exist in both fish and amphibian, and no
other gel-forming mucins were identified in those species, which
further suggests that MUC19 may be more ancient than the
other four. Interestingly, MUC19 is located at the same
chromosome (chromosome 12) as VWF, whereas the other four
mucins are located on chromosome 11 (chromosome 11p15). It
is tempting to speculate that it was the first duplication event
that created the ancient MUC19 and VWF, and then a trans-
location event led to the formation of the 11p15 mucin ancestor
gene, which further generated MUC2, -5AC, -5B, and -6
through multiple duplication events. Based on our analyses, in
chromosome 11p15, it appears that MUC6 was separated first,
then MUC2, and the appearance of MUC5AC and MUC5B was
the most recent event. The conservation of MUC19 across
species, even in primitive species, such as fish and amphibian,
suggests that it may have a very important function.
Although the full-length sequences of both pig (21) and
mouse (12) MUC19/Muc19 have been reported, the most
important ortholog—human MUC19—had only been partially
sequenced (4), which is why we determined to completely
sequence this mucin in the present study. Interestingly, in contrast
to the well held belief that orthologs should have identical
structures, human MUC19 has two unique features that are
different from its pig or mouse counterparts. First, human
MUC19 has an unusually long N terminus, which contains
serine-rich repetitive sequences and is encoded by HVR.
Multiple alternative splicing forms have been identified from
HVR. Because those transcripts were amplified from the
mixed RNA samples of multiple adult tracheas or salivary
glands, it is still unclear if an individual has all those tran-
scripts, or if they come from different people, which may be an
Figure 5. Phylogenetic analysis of gel-forming mucin family. Protein
sequences were obtained from GenBank on the following accession
numbers: hMUC2, NP_002448; mMuc2, NP_076055; rMuc2, Q62635;
hMUC5AC, P98088; mMuc5ac, NP_034974; rMuc5ac, XP_001063331;
hMUC5B, NP_002449; mMuc5b, NP_083077; rMuc5b, XP_238988;
hMUC6, NP_005952; mMuc6, EDL18119; rMuc6, XP_215127;
hMUC19, HM801842; pMUC19, NP_001106757; mMuc19,
NP_997126; rMuc19, XP_002729892; Ovomucin, BAB21488; FIMB.1,
CAA69604; Spiggin1_1, BAE92619; Spiggin1_2, BAE92620; Spiggin1_3,
BAE92621; Spiggin4, BAE92625; hVWF, AAB59458. h, human; m,
mouse; p, pig; r, rat. Phylogenetic analysis methods are described in
the MATERIALS AND METHODS.
Figure 6. RT-PCR analyses of MUC19 expres-
sion. The pair of primers for MUC19_3 end is
M19RT14, and for MUC19_5 end is M19RT15.
Actin was used as a control. All primer sequences
are listed in Table 2. Ag, adrenal gland; Bc, brain,
cerebellum; Bm, bone marrow; Br, brain
(whole); Fb, fetal brain; Fl, fetal liver; He, heart;
Ki, kidney; Li, liver; Lu, lung (whole); M, molec-
ular marker; Pl, placenta; Pr, prostate; Sc, spinal
cord; Sg, salivary gland; Sm, skeletal muscle; Sp,
spleen; Te, testis; Tr, trachea; Ty, thymus; Ut,
uterus.
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interesting project to pursue in the future. As discussed in the
RESULTS section, the peptide encoded by HVR appears to be
structurally similar to Smgc (13), a protein encoded by an
alternative transcript from the same rodent Muc19 locus (12). In
rodent, Smgc is an individual gene and is expressed almost
exclusively in the neonatal salivary tissues (12, 13), which are
not present in our multiple tissue panel. In adult tissue, even the
shortest HVR contains eight additional exons upstream of the
first VWD domain. Although most of the HVR transcripts
encode peptides in the same ORF with the rest of MUC19, two
splicing forms (HVR_14 or HM801856 and HVR_15 or
HM801857) can only be translated into truncated peptides,
suggesting a potential regulation point of MUC19 expression
through alternative splicing at HVR. Another interesting fea-
ture of MUC19 is its threonine-rich repeats in the central exon,
which differs from the serine-rich repeats in its mouse ortholog
(12). In addition, the central exon of human MUC19 encodes
mostly the mixed repeats that are similar to human MUC5B
(22). In contrast, the central exon of pig MUC19 (21) or mouse
Muc19 (12) encodes mostly the identical tandem repeats. Thus,
human MUC19 may have a different glycosylation pattern or
physical properties than its counterparts in other species.
Through the cloning process, we have identified a missing
genomic sequence that covers MUC19 exons 70–81. The re-
petitive region is usually difficult to assemble when using the
popular ‘‘shotgun’’ approach, which assembles DNA fragments
based on the similarities at each end (26). Thus, if the DNA
ends share considerable similarity (e.g., those located in the
repetitive regions of mucin), this approach would have gener-
ated an erroneous assembly (26). Thus, genes constraining a
large stretch of repetitive sequences should be very prone to
assembly errors, and extreme caution should be taken when
using the current genome assembly for research on those genes
(e.g., mucins). In the present work, because we used published
human genome sequences to determine the central exon, it is
possible that there are assembly errors in those highly repetitive
sequences. Although we have used PCR to confirm some parts
of this region, the extreme difficulty in amplifying the repetitive
sequences prevented us from examining the entire central exon.
In fact, except for the relatively small gel-forming mucins (i.e.,
MUC2 and MUC6), the central exon sequences of the large
mucins are either not completed (e.g., MUC5AC) or conceptu-
ally derived from genomic sequences (e.g., MUC5B [22], pig
MUC19 [21], mouse Muc19 [12], etc.). Thus, the accuracy of the
central exon sequences has actually been determined by the
accuracy of human genome assembly. Nonetheless, we have
verified MUC19 integrity by using both PCR and antibody
staining with primers/antibodies against either 59 end/N terminus
or 39 end/C terminus. As expected, similar gene expression or
staining patterns were observed. Thus, we are confident that we
indeed obtained the complete human MUC19 gene sequence.
In addition to verifying the integrity of MUC19 cDNA, the
gene expression results (i.e., tracheal submucosal gland and
salivary gland) from both mRNA and proteins levels have
confirmed the MUC19 tissue expression pattern reported pre-
viously (4), which is also identical to the expressions of both
mouse Muc19 (14) and pig MUC19 (21). Thus, MUC19 should
be one of the major mucin proteins present in both airway mucus
and saliva. Interestingly, a recent study (27) found that MUC19
could not be detected in unstimulated human saliva samples, but
was present abundantly in stimulated saliva samples from
various animals (i.e., horse, pig, cow, rat, and mouse). Because
it has been known that the viscosity (also the mucin content) of
the stimulated and unstimulated saliva is very different (28) (Dr.
David Culp, University of Florida, personal communication), the
secretion of MUC19 may well be under neuronal or hormonal
control, a concept that will require further study.
In summary, we have cloned and sequenced the human
MUC19 gene. Sequence analyses have indicated both the hall-
mark gel-forming mucin structure (i.e., VWD-VWD-VWD-
threonine/serine–rich repeats-VWC-CT) and some distinctive
features (i.e., HVR, threonine-dominant repeats). Phylogenetic
analysis revealed ancient footage of the MUC19 gene up to fish
and amphibian. This information should facilitate future un-
derstanding of the function and regulation of MUC19 in health
and disease.
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